trial · primary record
AMT-116
NSCLC (Advanced Non-small Cell Lung Cancer)
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 512 |
| Primary completion | 2028-12-30 |
| Primary endpoint | Number of Participants with Adverse Events as Assessed by CTCAE v6.0 |
| Registry ID | NCT07718737 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:51.165Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07718737
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.